BEIJING, Oct. 30, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, November 13, 2025, at 4:30 p.m.

Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the ...

Conference Call Scheduled for Thursday, November 13, 2025 at 4:30 pm ET. SARATOGA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage med ...

The webcast will feature an overview of the quarter from Jason Matuszewski, CEO, and Brandon Poe, CFO. To register for the event, please click HERE. Conference Call & Webcast Information: About ...

Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will ...

Less Frequent Acute Care Utilization: CA PCP attribution was associated with significantly less acute care utilization, including fewer all-cause inpatient hospitalizations (ranging from -7.6% to ...

DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors ...

WESTBROOK, Maine, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that it plans to ...

The Artiva management team will also be available to participate in investor meetings with investors who are registered to attend the conferences.

RADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered ...